Literature DB >> 23073868

Antimicrobial resistance in internal medicine wards.

Francesco Menichetti1, Enrico Tagliaferri.   

Abstract

Antimicrobial resistance is a global medical problem, affecting most bacterial pathogens. The major challenges are currently posed by methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-resistant enterococci (VRE), Enterobacteriaceae producing extended-spectrum-beta-lactamases (ESBL) and carbapenemases, and multi-resistant strains of Pseudomonas aeruginosa and Acinetobacter baumannii. Therapeutic options are very limited and, in some cases, virtually unavailable. This article provides an overview of the recent epidemiological trends exhibited by the most important multi-resistant pathogens, and of the treatment options that are currently available for these infections.

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 23073868     DOI： 10.1007/s11739-012-0828-3

Source DB:  PubMed          Journal:  Intern Emerg Med        ISSN： 1828-0447            Impact factor:   3.397


  7 in total

1.  Antimicrobial stewardship in an Internal Medicine ward: effects on antibiotic consumption and on the use of carbapenems.

Authors:  Alberto Fortini; Antonio Faraone; Massimo Di Pietro; Chiara Cappugi; Giovanna Magnante; Costanza Boccadori; Sara Bartolini; Loredana Rabatti
Journal:  Intern Emerg Med       Date:  2018-07-21       Impact factor: 3.397

2.  Unexpected challenges in treating multidrug-resistant Gram-negative bacteria: resistance to ceftazidime-avibactam in archived isolates of Pseudomonas aeruginosa.

Authors:  Marisa L Winkler; Krisztina M Papp-Wallace; Andrea M Hujer; T Nicholas Domitrovic; Kristine M Hujer; Kelly N Hurless; Marion Tuohy; Geraldine Hall; Robert A Bonomo
Journal:  Antimicrob Agents Chemother       Date:  2014-12-01       Impact factor: 5.191

3.  Phage Therapy Is Effective in a Mouse Model of Bacterial Equine Keratitis.

Authors:  Takaaki Furusawa; Hidetomo Iwano; Yutaro Hiyashimizu; Kazuki Matsubara; Hidetoshi Higuchi; Hajime Nagahata; Hidekazu Niwa; Yoshinari Katayama; Yuta Kinoshita; Katsuro Hagiwara; Tomohito Iwasaki; Yasunori Tanji; Hiroshi Yokota; Yutaka Tamura
Journal:  Appl Environ Microbiol       Date:  2016-08-15       Impact factor: 4.792

4.  Is methicillin-resistant Staphylococcus aureus a common pathogen in ventilation-associated pneumonia?: The experience of a tertiary teaching hospital in Jordan.

Authors:  Ziad A Elnasser; Haneen M Obeidat; Mo'ath E Bani-Salem; Zouhair O Amarin; Ali F Banni-Issa; Nasser M Kaplan
Journal:  Medicine (Baltimore)       Date:  2021-05-21       Impact factor: 1.817

5.  Bacteriophage ΦSA012 Has a Broad Host Range against Staphylococcus aureus and Effective Lytic Capacity in a Mouse Mastitis Model.

Authors:  Hidetomo Iwano; Yusuke Inoue; Takuji Takasago; Hironori Kobayashi; Takaaki Furusawa; Kotomi Taniguchi; Jumpei Fujiki; Hiroshi Yokota; Masaru Usui; Yasunori Tanji; Katsuro Hagiwara; Hidetoshi Higuchi; Yutaka Tamura
Journal:  Biology (Basel)       Date:  2018-01-09

6.  Pyelonephritis in Pediatric Uropathic Patients: Differences from Community-Acquired Ones and Therapeutic Protocol Considerations. A 10-Year Single-Center Retrospective Study.

Authors:  Giovanni Parente; Tommaso Gargano; Stefania Pavia; Chiara Cordola; Marzia Vastano; Francesco Baccelli; Giulia Gallotta; Laura Bruni; Adelaide Corvaglia; Mario Lima
Journal:  Children (Basel)       Date:  2021-05-23

7.  Efficacy Assessment of Phage Therapy in Treating Staphylococcus aureus-Induced Mastitis in Mice.

Authors:  Fei Teng; Xiaoyu Xiong; Songsong Zhang; Guiwei Li; Ruichong Wang; Lanlan Zhang; Xiaona Wang; Han Zhou; Jiaxuan Li; Yijing Li; Yanping Jiang; Wen Cui; Lijie Tang; Li Wang; Xinyuan Qiao
Journal:  Viruses       Date:  2022-03-16       Impact factor: 5.048
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.